SHC Relative Valuation
SHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SHC is overvalued; if below, it's undervalued.
Historical Valuation
Sotera Health Co (SHC) is now in the Fair zone, suggesting that its current forward PE ratio of 19.16 is considered Fairly compared with the five-year average of 19.60. The fair price of Sotera Health Co (SHC) is between 15.55 to 23.62 according to relative valuation methord.
Relative Value
Fair Zone
15.55-23.62
Current Price：18.80
Fair
19.16
PE
1Y
3Y
5Y
11.41
EV/EBITDA
Sotera Health Co. (SHC) has a current EV/EBITDA of 11.41. The 5-year average EV/EBITDA is 12.44. The thresholds are as follows: Strongly Undervalued below 5.48, Undervalued between 5.48 and 8.96, Fairly Valued between 15.92 and 8.96, Overvalued between 15.92 and 19.40, and Strongly Overvalued above 19.40. The current Forward EV/EBITDA of 11.41 falls within the Historic Trend Line -Fairly Valued range.
13.42
EV/EBIT
Sotera Health Co. (SHC) has a current EV/EBIT of 13.42. The 5-year average EV/EBIT is 14.47. The thresholds are as follows: Strongly Undervalued below 6.69, Undervalued between 6.69 and 10.58, Fairly Valued between 18.36 and 10.58, Overvalued between 18.36 and 22.26, and Strongly Overvalued above 22.26. The current Forward EV/EBIT of 13.42 falls within the Historic Trend Line -Fairly Valued range.
4.18
PS
Sotera Health Co. (SHC) has a current PS of 4.18. The 5-year average PS is 4.56. The thresholds are as follows: Strongly Undervalued below 1.15, Undervalued between 1.15 and 2.86, Fairly Valued between 6.27 and 2.86, Overvalued between 6.27 and 7.98, and Strongly Overvalued above 7.98. The current Forward PS of 4.18 falls within the Historic Trend Line -Fairly Valued range.
15.05
P/OCF
Sotera Health Co. (SHC) has a current P/OCF of 15.05. The 5-year average P/OCF is 15.26. The thresholds are as follows: Strongly Undervalued below -6.09, Undervalued between -6.09 and 4.58, Fairly Valued between 25.94 and 4.58, Overvalued between 25.94 and 36.62, and Strongly Overvalued above 36.62. The current Forward P/OCF of 15.05 falls within the Historic Trend Line -Fairly Valued range.
30.77
P/FCF
Sotera Health Co. (SHC) has a current P/FCF of 30.77. The 5-year average P/FCF is 22.33. The thresholds are as follows: Strongly Undervalued below -1.01, Undervalued between -1.01 and 10.66, Fairly Valued between 34.01 and 10.66, Overvalued between 34.01 and 45.68, and Strongly Overvalued above 45.68. The current Forward P/FCF of 30.77 falls within the Historic Trend Line -Fairly Valued range.
Sotera Health Co (SHC) has a current Price-to-Book (P/B) ratio of 9.13. Compared to its 3-year average P/B ratio of 9.73 , the current P/B ratio is approximately -6.15% higher. Relative to its 5-year average P/B ratio of 10.20, the current P/B ratio is about -10.49% higher. Sotera Health Co (SHC) has a Forward Free Cash Flow (FCF) yield of approximately 1.72%. Compared to its 3-year average FCF yield of -1.84%, the current FCF yield is approximately -193.84% lower. Relative to its 5-year average FCF yield of -0.09% , the current FCF yield is about -2002.02% lower.
9.13
P/B
Median3y
9.73
Median5y
10.20
1.72
FCF Yield
Median3y
-1.84
Median5y
-0.09
Competitors Valuation Multiple
The average P/S ratio for SHC's competitors is 100.38, providing a benchmark for relative valuation. Sotera Health Co Corp (SHC) exhibits a P/S ratio of 4.18, which is -95.83% above the industry average. Given its robust revenue growth of 9.05%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SHC increased by 36.62% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 5.95 to 15.55.
The secondary factor is the Revenue Growth, contributed 9.05%to the performance.
Overall, the performance of SHC in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
CXT
Crane NXT Co
48.16USD
-3.45%
KFY
Korn Ferry
66.59USD
0.00%
IAC
IAC Inc
38.58USD
-2.50%
GFF
Griffon Corp
74.46USD
-2.41%
SKT
Tanger Inc
33.92USD
-0.38%
FROG
Jfrog Ltd
62.96USD
6.39%
RUM
Rumble Inc
6.61USD
-1.64%
ASO
Academy Sports and Outdoors Inc
56.89USD
-2.77%
NPO
Enpro Inc
221.66USD
-1.92%
VKTX
Viking Therapeutics Inc
32.38USD
0.25%
Frequently Asked Questions
Is Sotera Health Co (SHC) currently overvalued or undervalued?
Sotera Health Co (SHC) is now in the Fair zone, suggesting that its current forward PE ratio of 19.16 is considered Fairly compared with the five-year average of 19.60. The fair price of Sotera Health Co (SHC) is between 15.55 to 23.62 according to relative valuation methord.
What is Sotera Health Co (SHC) fair value?
SHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Sotera Health Co (SHC) is between 15.55 to 23.62 according to relative valuation methord.
How does SHC's valuation metrics compare to the industry average?
The average P/S ratio for SHC's competitors is 100.38, providing a benchmark for relative valuation. Sotera Health Co Corp (SHC) exhibits a P/S ratio of 4.18, which is -95.83% above the industry average. Given its robust revenue growth of 9.05%, this premium appears unsustainable.
What is the current P/B ratio for Sotera Health Co (SHC) as of Jan 07 2026?
As of Jan 07 2026, Sotera Health Co (SHC) has a P/B ratio of 9.13. This indicates that the market values SHC at 9.13 times its book value.
What is the current FCF Yield for Sotera Health Co (SHC) as of Jan 07 2026?
As of Jan 07 2026, Sotera Health Co (SHC) has a FCF Yield of 1.72%. This means that for every dollar of Sotera Health Co’s market capitalization, the company generates 1.72 cents in free cash flow.
What is the current Forward P/E ratio for Sotera Health Co (SHC) as of Jan 07 2026?
As of Jan 07 2026, Sotera Health Co (SHC) has a Forward P/E ratio of 19.16. This means the market is willing to pay $19.16 for every dollar of Sotera Health Co’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Sotera Health Co (SHC) as of Jan 07 2026?
As of Jan 07 2026, Sotera Health Co (SHC) has a Forward P/S ratio of 4.18. This means the market is valuing SHC at $4.18 for every dollar of expected revenue over the next 12 months.